
Opinion|Videos|July 3, 2024
Current and Emerging Treatment Options and Management of Duchenne Muscular Dystrophy
Author(s)Emma Ciafaloni, MD
An expert on Duchenne muscular dystrophy reviews standard-of-care treatment options and provides clinical insights on adverse effects and safety concerns, particularly with corticosteroids.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- Please briefly describe the current standard of care for Duchenne muscular dystrophy (DMD).
- What are the side effects and/or safety concerns associated with long-term use of corticosteroids in patients with DMD?
- Discuss recent approvals and ongoing studies in DMD.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
From Diagnosis to Treatment: Key Questions in Immune-Mediated Small Fiber Neuropathy
2
Current Treatment Strategies for Dravet Syndrome
3
NeurologyLive®'s Conference Coverage, Oveporexton Displays Symptom Improvement in NT1, FDA Allows BLA for AMT-130 in HD
4
Beyond Motor Symptoms: The Power of Connection in Parkinson Disease
5















